Drug intelligence / Profile preview

Panax notoginseng (Sun Ten)

Development stage
Unknown
Lead developer
Sun Ten
Administration
Oral
01

Overview

Panax notoginseng, commonly known as Sanqi or Notoginseng, is a perennial herb in the Araliaceae family and a cornerstone of Traditional Chinese Medicine (TCM). Sun Ten Laboratories provides this botanical as a concentrated herbal extract, typically in a 5:1 ratio, for use in clinical TCM practice. The herb is traditionally classified as a hemostatic agent that also possesses the unique ability to 'invigorate blood,' meaning it can stop bleeding without causing blood stasis. Its primary active constituents are dammarane-type triterpene saponins, specifically notoginsenosides (such as Notoginsenoside R1) and ginsenosides (such as Rb1, Rg1, and Rd). These compounds are studied for their multi-target effects on the cardiovascular system, including the inhibition of platelet aggregation, reduction of inflammatory cytokines, and protection of vascular endothelial cells. Sun Ten markets this product as a dietary supplement and herbal ingredient rather than a regulated pharmaceutical drug.

Brand names
San QiNotoginseng
Other names
SanqiTienchi ginsengThree-seven ginsengMountain plantRadix Notoginseng
02

Targets

TLR4 (Toll-like receptor 4)NF-κBIRAK1 (Interleukin-1 receptor-associated kinase 1)NOS2 (Nitric Oxide Synthase 2)GP1BA (Platelet glycoprotein ib alpha chain)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on Panax notoginseng (Sun Ten).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panax notoginseng (Sun Ten).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call